Aurobindo Pharma reported INR350.34B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Cipla INR 329.19B 16.3B Sep/2025
Divis Laboratories Ltd INR 154.13B 4.44B Sep/2025
Dr.Reddys Laboratories INR 375.76B 13.67B Dec/2025
Hindustan Unilever INR 487.16B 8.93B Sep/2025
Sun Pharmaceuticals INR 778.2B 56.02B Sep/2025
UPL INR 318.94B 59.32B Sep/2025